Clinical Trials Directory

Trials / Completed

CompletedNCT01737840

Comparison of Pantoprazole and Ranitidine in Dyspepsia

Intravenous Pantoprazole vs Ranitidine in Dyspepsia in Emergency Department: A Randomized Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Akdeniz University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The H0 hypothesis of the study is there is no difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department. The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

Detailed description

Dyspepsia is one of the common complaints in emergency department. Proton pomp inhibitors, H2 receptor blockers and anti-acids are common drugs for treating dyspepsia in emergency department. However there is no study in the emergency department comparing the effectiveness of these drugs. So the investigators planned this study which drug is effective in these patients in order to provide a cost-effective treatment in dyspeptic patients.

Conditions

Interventions

TypeNameDescription
DRUGPantoprazole33 patients
DRUGRanitidine33 patients

Timeline

Start date
2012-10-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2012-11-30
Last updated
2015-07-23
Results posted
2015-07-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01737840. Inclusion in this directory is not an endorsement.